EU Manufacturer
๐จ๐ณ China
Active
Hebei Xinle Sci&Tech Co., Ltd
SRN: CN-MF-000016692
ยท
No.2, Xingye Street, Xinle City No.2, 050700 Shijiazhuang City, Hebei Province, China
Basic UDI-DIs
65
Total Devices
309
On Market
309
Off Market
0
Certificates
1
Valid
0
Expiring < 6mo
0
Countries
32
Basic Information
- Address
- No.2, Xingye Street, Xinle City No.2, 050700 Shijiazhuang City, Hebei Province, China
- [email protected]
- Phone
- +86-15097339955
Regulatory Overview
Regulation
Loading...
Eu Mdd
44
Eu Ivdr
16
Eu Mdr
5
Classification
Loading...
Eu Md Class 2a
48
Eu Ivd Class A
16
Eu Md Class 1
1
Certificate Health
Total
1
Valid
0
Expiring < 6mo
0
Expired / Withdrawn
1
Certificates by Expiry Year
Loading...
| Type | Number | Expiry Date | Status | |||
|---|---|---|---|---|---|---|
| MDD Annex V | G2 065764 0004 | TรV SรD Product Service GmbH | May 26, 2024 |
Market Presence
Devices from this manufacturer are available in 32 countries across Europe.
๐ฆ๐น Austria
๐ง๐ช Belgium
๐ง๐ฌ Bulgaria
๐จ๐พ Cyprus
๐จ๐ฟ Czechia
๐ฉ๐ช Germany
๐ฉ๐ฐ Denmark
๐ช๐ช Estonia
๐ฌ๐ท Greece
๐ช๐ธ Spain
๐ซ๐ฎ Finland
๐ซ๐ท France
๐ญ๐ท Croatia
๐ญ๐บ Hungary
๐ฎ๐ช Ireland
๐ฎ๐ธ Iceland
๐ฎ๐น Italy
๐ฑ๐ฎ Liechtenstein
๐ฑ๐น Lithuania
๐ฑ๐บ Luxembourg
๐ฑ๐ป Latvia
๐ฒ๐น Malta
๐ณ๐ฑ Netherlands
๐ณ๐ด Norway
๐ต๐ฑ Poland
๐ต๐น Portugal
๐ท๐ด Romania
๐ธ๐ช Sweden
๐ธ๐ฎ Slovenia
๐ธ๐ฐ Slovakia
๐น๐ท Tรผrkiye
๐ฌ๐ง United Kingdom
Device Portfolio
| Name | ||||
|---|---|---|---|---|
| GLUCO-CARE Safety Lancets | EU MDR | Eu Md Class 2a | On Market | 0 |
| GLUCO-CARE Safety Lancets | EU MDR | Eu Md Class 2a | On Market | 0 |
| GLUCO-CARE Safety Lancets | EU MDR | Eu Md Class 2a | On Market | 0 |
| GLUCO-CARE Safety Lancets | EU MDR | Eu Md Class 2a | On Market | 0 |
| GLUCO-CARE Safety Lancets | EU MDR | Eu Md Class 2a | On Market | 0 |
| GLUCO-CARE Safety Lancets | EU MDR | Eu Md Class 2a | On Market | 0 |
| GLUCO-CARE Safety Lancets | EU MDR | Eu Md Class 2a | On Market | 0 |
| GLUCO-CARE Safety Lancets | EU MDR | Eu Md Class 2a | On Market | 0 |
| Holder | EU MDR | Eu Md Class 1 | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |
| Lancet | EU MDR | Eu Md Class 2a | On Market | 0 |